Where did #theranos make a mistake? #bloodtest #biomarkers #bloodtests
27 Oct 2023 · 1 min

0:52
A short YouTube discussion (uploaded Oct 27, 2023 by Josh Trent) examining where Theranos erred and how that reflects broader risks in blood-testing and deep-tech startups. The speaker argues Theranos overpromised: they solicited doctors’ wish-lists (hundreds of tests), promised to deliver with little concrete plan, excelled at fundraising and selling a vision, and therefore could sustain years of hype without launching—creating real patient harm and inviting deep scrutiny. The clip contrasts this with general technology startups where strong salesmanship can mask lack of execution until later.










